Taken together, these data suggest that rIL-1RA could be a beneficial alternative for the inhibition of tumor-dependent angiogenesis, probably by reducing the production of VEGF, CXCL8, endothelin-1, IL-1β and hepatocyte growth factor (HGF) [164–166]. This evidence concerns the gene CXCL8 and neoplasm.